KARA BURNS: Open Payments
NPI 1518472216 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 20 payments from 6 companies in 2025. Trend: 2023 $168 · 2024 $321 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $408 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Averitas Pharma Inc. | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
Products named: PROCLAIM, RELISTOR, ZEPBOUND, QUTENZA, IONICRF, Exparel, Wegovy.
Industry payments across AL — which companies pay providers there.
